Glucagon Suppressed Proliferation Rate of Mammary Aplastic Carcinoma in Mice
- 1 June 1980
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 12 (06) , 243-246
- https://doi.org/10.1055/s-2007-996258
Abstract
Glucagon injected into mice with mammary aplastic carcinoma retards the growth and prolongs the mean survival time of the animals. Glucagon stimulates the plaque-forming capacity and phagocytosis in tumor-bearing animals. Cyclophosphamide treatment abolishes the antitumor effect of glucagon, while the effect of the hormone is enhanced in Corynebacterium parvum [Propionibacterium acnes] pretreated animals. The tumor-retarding effects of glucagon apparently are mediated mainly by maintaining high B [bone marrow-derived cell]-type reactivity and phagocytosis.This publication has 5 references indexed in Scilit:
- Aplastic Carcinoma in Diabetic Mice: Hyperglycemia-Suppressed Proliferation Rate and Insulin Synthesis by Tumor CellsJNCI Journal of the National Cancer Institute, 1979
- Recovery of Immune System in Diabetic Mice after Treatment with InsulinHormone and Metabolic Research, 1978
- The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation.The Journal of Experimental Medicine, 1977
- Kinetics of the reactive cell clones after immunosuppression and induction of tolerance: (1) Inhibition of 19 S and 7 S plaque-forming cells in the primary and secondary immune response to sheep red blood cells by cyclophosphamide and 036.5122 (Asta)Inflammation Research, 1975
- ANTI-TUMOR ACTIVITY OF GLUCAGON1959